| Bayesian cost-effectiveness analysis with the R package BCEA G Baio, A Berardi, A Heath Springer, 2017 | 58 | 2017 |
| The use of fibrin sealant during non-emergency surgery: a systematic review of the evidence of benefits and harms SJ Edwards, F Crawford, MH van Velthoven, A Berardi, G Osei-Assibey, ... Health Technology Assessment, 2017 | 34 | 2017 |
| Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing–remitting multiple sclerosis: adjusting for … A Berardi, MK Siddiqui, C Treharne, G Harty, SL Wong Current Medical Research and Opinion, 2019 | 21 | 2019 |
| BCEA: Bayesian cost effectiveness analysis G Baio, A Berardi, A Heath R package version 2 (6), 2018 | 10 | 2018 |
| BCEA: Bayesian Cost Effectiveness Analysis, 2016 G Baio, A Berardi, A Heath R package version, 2.2-3, 2016 | 5 | 2016 |
| BCEAweb: A User-Friendly Web-App to Use BCEA G Baio, A Berardi, A Heath, G Baio, A Berardi, A Heath Bayesian cost-effectiveness analysis with the R package BCEA, 153-166, 2017 | 4 | 2017 |
| Economic evaluation of sequencing strategies in the treatment of psoriatic arthritis in the United States T Tencer, Z Clancy, H Cawston, V Damera, A Berardi, S Cure Value in Health 17 (3), A46, 2014 | 3 | 2014 |
| EE357 Cost per Responder Analysis Comparing Adagrasib and Sotorasib in Patients With KRAS G12C-Mutated Previously Treated Non-Small Cell Lung Cancer (NSCLC) A Berardi, M Laurie, C Theriou, I Orsini, W Bouwmeester, S Gao, ... Value in Health 26 (12), S119-S120, 2023 | | 2023 |
| CO95 Matching-Adjusted Indirect Comparison (MAIC) in Previously Treated KRAS G12C-Mutated Advanced/Metastatic Non-Small Cell Lung Cancer (a/mNSCLC): Adagrasib Versus Sotorasib W Bouwmeester, M Laurie, B Korytowsky, M Grevinga, C Qian, A Berardi, ... Value in Health 26 (12), S31, 2023 | | 2023 |
| PNS128 STILL EXCELLING? AN ASSESSMENT OF SOFTWARE USED IN NICE SINGLE TECHNOLOGY APPRAISALS AND ICER REPORTS IN 2019 C Treharne, MD Rodriguez-Rey, R Macaulay, A Berardi Value in Health 23, S308, 2020 | | 2020 |
| PCN121 LONG-TERM COST-EFFECTIVENESS MODELING COMPARING MATURITY OF DATA CUTS: A COMPARISON BETWEEN COST-EFFECTIVENESS OF NIVOLUMAB VS EVEROLIMUS IN SECOND LINE RENAL CELL … H Sandhu, A Berardi Value in Health 23, S44, 2020 | | 2020 |
| HT1 EVIDENCE OF METHODOLOGICAL HETEROGENEITY IN THE NICE APPRAISAL PROCESS DEPENDING ON ERG: A REVIEW OF SURVIVAL EXTRAPOLATION APPROACHES IN ONCOLOGY A Berardi, K Hounsell, D Erim, R Macaulay Value in Health 23, S6, 2020 | | 2020 |
| WHAT IS WORTH KNOWING AT EARLY DEVELOPMENT? VALUE OF INFORMATION ANALYSIS USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A CASE STUDY E Wu, A Berardi, M Berling, C Smare, Y Yuan, S Wagner ISPOR Europe 2019, 2019 | | 2019 |
| ACCELERATING EARLY COST-EFFECTIVENESS MODELING IN ONCOLOGY USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A RETROSPECTIVE CASE STUDY OF NIVOLUMAB PRE-TREATED METASTATIC SMALL … E Wu, A Berardi, M Berling, C Smare, Y Yuan, S Wagner ISPOR Europe 2019, 2019 | | 2019 |
| PNS206 AIM FOR THE STARS, REACH THE MOON? A SIMPLE STRATEGY TO IMPROVE ADDITIONAL BENEFIT OUCTOMES IN GERMANY? R Macaulay, A Jakel, I Kasli, A Berardi Value in Health 22, S795, 2019 | | 2019 |
| PNS281 DO SPANISH TPRS AFFECT THE NATIONAL PRICING AND REIMBURSEMENT OF DRUGS? R Macaulay, A Berardi, RF Dacosta Value in Health 22, S810, 2019 | | 2019 |
| PCN219 WHAT IS WORTH KNOWING AT EARLY DEVELOPMENT? VALUE OF INFORMATION ANALYSIS USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A CASE STUDY E Wu, A Berardi, M Berling, C Smare, Y Yuan, S Wagner Value in Health 22, S478, 2019 | | 2019 |
| PCN181 ACCELERATING EARLY COST-EFFECTIVENESS MODELING IN ONCOLOGY USING AN INDICATION-AGNOSTIC WEB-BASED PLATFORM: A RETROSPECTIVE CASE STUDY OF NIVOLUMAB PRE-TREATED … E Wu, A Berardi, M Berling, C Smare, Y Yuan, S Wagner Value in Health 22, S471, 2019 | | 2019 |
| PNS42 R NICE LAGGING BEHIND THE WORLD? A Berardi, C Treharne, R Macaulay Value in Health 22, S293, 2019 | | 2019 |
| PCN199 THE IMPACT OF PCODR COMING UNDER THE REMIT OF CADTH: 3 YEAR UPDATE R Macaulay, A Berardi, P Bhayani Value in Health 22, S93, 2019 | | 2019 |
